Skip to content
  • ORCID
  • WoS
  • Google Scholar
  • Scopus
  • LinkedIn
  • BlueSky
Lombardi Research Lab

Lombardi Research Lab

Pioneering BioNano Engineering for Peptide Therapeutics, Advanced Biomaterials and Bioinspired Solutions

  • Welcome
  • Research
    • Research Overview
    • Current Projects
    • Previous Projects
  • Publications
  • Team
  • News and Events
  • Gallery
  • Join us
  • EDI
  • Contact
  • Toggle search form
cost snoopy bioactive peptides

Lucia is in the WG 2 and 3 of the European network SNOOPY

Posted on January 10, 2025April 27, 2025 By Lombardi Research Lab

The COST Action “Nanostructured or pOre fOrming Peptides for therapY” SNOOPY brings together a network of experts and young researchers from diverse disciplines (chemistry, biology, biochemistry, materials science, nanotechnology, medicine, physics) to overcome existing barriers to predict and implement bioactive peptides’ ability to self-assemble into functional nanostructures, including those at the interface with membranes, potentially forming pores and channels. This is a fast-growing field with enormous potential for therapy (including targeted cancer therapy, drug delivery, amyloidosis inhibition, regenerative medicine, membrane channels, and antimicrobials), and for the development of nanotechnological tools that could include potential use in diagnostics, optics, catalysis, and bioelectronics. Theoreticians and experimentalists of the SNOOPY Action will synergize to enable in silico predictions of self-assembly behavior, as well as to develop new advanced characterization methods, and to produce them and test them too. The expertise gathered by the Action will be applied to train and build the career of younger members. The geopolitical balance of the Action is strategically set to level the gap between COST Members, and to make of its diversity a tactical asset to boost creativity and foster new ideas. The Action will have socioeconomical impact through the search for new diagnostic and therapeutic solutions to address some of the most formidable challenges of the society (e.g., advance our understanding of amyloidoses and antimicrobial resistance), to assist scientists and industry in the development of new technologies (e.g., peptide nanostructures as vaccine adjuvants) and to develop more sustainable processes (e.g., greener peptide synthesis, or using peptides as biodegradable substitutes to polluting alternatives

news

Post navigation

Previous Post: NEW PAPER: Advancements in Loop Cyclization Approaches for Enhanced Peptide Therapeutics for Targeting Protein–Protein Interactions
Next Post: NEW PAPER: Confinement and Catalysis within De Novo Designed Peptide Barrels

More Related Articles

Lucia joins BBSRC People and Talent Advisory Pool news
Happy New Year news
Open Fellowship Scheme news
PhD Scholarships for Students from China news
Academic Lead for EDI equality, diversity and inclusion in science
Imperial College London – Sabanci University Workshop on Emerging Technologies! news

Categories


  • awards and prizes
  • equality, diversity and inclusion in science
  • funding
  • interviews
  • news
  • past events
  • publications
  • recruitment
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Dec    

Archives


  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • July 2025
  • May 2025
  • April 2025
  • January 2025
  • November 2024
  • June 2024
  • October 2023

Office and Lab

School of Biological Sciences
Queen's University Belfast
19 Chlorine Gardens
Belfast, BT9 5DL
United Kingdom

Other affiliation

Department of Chemical Engineering
Imperial College London
South Kensington Campus
London, SW7 2AZ
United Kingdom

Contacts

l.lombardi@qub.ac.uk
l.lombardi@imperial.ac.uk
+44 28 9097 1096

Lombardi Research Lab.

Powered by PressBook Green WordPress theme